Ki-67 expression predicts biochemical recurrence after radical prostatectomy in the setting of positive surgical margins

被引:8
作者
Shahait, Mohammed [1 ]
Nassif, Samer [2 ]
Tamim, Hani [3 ]
Mukherji, Deborah [3 ]
Hijazi, Maya [2 ]
El Sabban, Marwan [4 ]
Khauli, Raja [1 ]
Bulbul, Muhammad [1 ]
Abou Kheir, Wassim [4 ]
El Hajj, Albert [1 ]
机构
[1] Amer Univ Beirut, Med Ctr, Fac Med, Div Urol, POB 11-0236, Beirut 11072020, Lebanon
[2] Amer Univ Beirut, Dept Pathol, Fac Med, Med Ctr, POB 11-0236, Beirut 11072020, Lebanon
[3] Amer Univ Beirut, Dept Internal Med, Fac Med, Med Ctr, POB 11-0236, Beirut 11072020, Lebanon
[4] Amer Univ Beirut, Dept Physiol, Fac Med, Med Ctr, POB 11-0236, Beirut 11072020, Lebanon
关键词
Ki-67; Positive surgical margin; Radical prostatectomy; Biochemical recurrence; Prostate cancer; RETROPUBIC PROSTATECTOMY; INDEPENDENT PREDICTOR; DISTANT METASTASIS; AFRICAN-AMERICAN; PROGRESSION; MORTALITY; RADIOTHERAPY; ANTIGEN; IMPACT; MIB-1;
D O I
10.1186/s12894-018-0330-y
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Positive surgical margin (PSM) is a predictor of biochemical recurrence (BCR) following radical prostatectomy (RP). Attempts to stratify PSM based on linear length, Gleason score, location and number have failed to add to predictive models using margin status alone. We evaluated the prognostic significance of Ki-67 expression in this setting. Methods: Immunohistochemical staining for Ki-67 was done on prostatectomy specimens from 117 patients who had a PSM. Ki67 expression was measured at the margin and in the index lesion. Patients were dichotomized based on Ki-67 expression into three groups. Group 1 with no Ki-67 expression, Group 2 with Ki-67 <= 2%, and Group 3 with Ki-67 >= 3%. To eliminate the impact of the adjuvant treatment (AT) on the outcome, data were analyzed by the Cox proportional hazards in which AT was Considered as a time-dependent covariate. Results: The discordance rate of Ki-67 expression between matched index lesion and margin specimens was 44/117 (37.6%). There was a trend for higher risk of BCR (HR: 2.06, (0.97-4.43), P = 0.06) in patients expressing high Ki67 at the surgical margin although this was not statistically significant. However High Ki-67 expression in the index lesion was an independent predictive factor for BCR in this subset of patients. (HR: 4, (1.64-9.80), P = 0.002). Conclusion: High Ki67 expression in the index prostate cancer lesion is an independent predictor of BCR in patients with positive surgical margin following radical prostatectomy. Our findings need to be validated in a larger cohort.
引用
收藏
页数:6
相关论文
共 25 条
[1]  
Bubendorf L, 1996, J PATHOL, V178, P437, DOI 10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO
[2]  
2-4
[3]   MONOCLONAL-ANTIBODIES AGAINST RECOMBINANT PARTS OF THE KI-67 ANTIGEN (MIB-1 AND MIB-3) DETECT PROLIFERATING CELLS IN MICROWAVE-PROCESSED FORMALIN-FIXED PARAFFIN SECTIONS [J].
CATTORETTI, G ;
BECKER, MHG ;
KEY, G ;
DUCHROW, M ;
SCHLUTER, C ;
GALLE, J ;
GERDES, J .
JOURNAL OF PATHOLOGY, 1992, 168 (04) :357-363
[4]   Adjuvant radiotherapy following radical prostatectomy for prostate cancer [J].
Daly, Tiffany ;
Hickey, Brigid E. ;
Lehman, Margot ;
Francis, Daniel P. ;
See, Adrienne M. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12)
[5]  
EPSTEIN JI, 1993, CANCER-AM CANCER SOC, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO
[6]  
2-Y
[7]   Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Dikshit, Rajesh ;
Eser, Sultan ;
Mathers, Colin ;
Rebelo, Marise ;
Parkin, Donald Maxwell ;
Forman, David ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386
[8]   Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: Data from the CaPSURE database [J].
Grossfeld, GD ;
Chang, JJ ;
Broering, JM ;
Miller, DP ;
Yu, J ;
Flanders, SC ;
Henning, JM ;
Stier, DM ;
Carroll, PR .
JOURNAL OF UROLOGY, 2000, 163 (04) :1171-1177
[9]  
Guo YP, 2000, PROSTATE, V42, P130, DOI 10.1002/(SICI)1097-0045(20000201)42:2<130::AID-PROS7>3.0.CO
[10]  
2-3